ZyVersa Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 2785.7%.

Top 21 shareholders own 5.95% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
2.12%	Anson Group	16,067	US$85.0k	0%	0.01%
0.56%	INCON Co.,Ltd.	4,278	US$22.6k	0%	no data
0.5%	Alpha Capital Anstalt	3,789	US$20.0k	0%	0.08%
0.47%	Dominion Capital LLC	3,560	US$18.8k	0%	72.71%
0.47%	Ayrton Capital LLC	3,560	US$18.8k	0%	0.19%
0.47%	3i, LP	3,560	US$18.8k	0%	no data
0.34%	Walleye Capital LLC	2,586	US$13.7k	0%	no data
0.25%	Two Sigma Securities, LLC, Asset Management Arm	1,867	US$9.9k	0%	no data
0.2%	Citadel Advisors LLC	1,498	US$7.9k	0%	no data
0.17%	Stephen Glover	1,308	US$6.9k	0%	no data
0.17%	A.G.P. / Alliance Global Partners Corp.	1,286	US$6.8k	0%	0.02%
0.052%	Tower Research Capital LLC	398	US$2.1k	2,390%	no data
0.051%	Asclepius Life Sciences Fund, L.P.	386	US$2.0k	0%	no data
0.046%	Geode Capital Management, LLC	351	US$1.9k	0%	no data
0.043%	UBS Asset Management AG	327	US$1.7k	32,600%	no data
0.017%	Peter Wolfe	128	US$677.0	0%	no data
0.016%	MedicaRx Inc	125	US$661.3	0%	no data
0.0097%	Pablo Guzman	74	US$391.3	0%	no data
0.0065%	The Vanguard Group, Inc.	49	US$259.1	0%	no data
0.00013%	Wells Fargo & Company, Securities and Brokerage Investments	1	US$5.2	0%	no data
0.00013%	Wells Fargo & Company, Private Banking and Investment Banking Arm	1	US$5.2	0%	no data